Health Condition 1: E611- Iron deficiency
Conditions
Interventions
Intervention1: IFA and Vitamin D3: Study participants in this group will receive daily 60 mg of elemental oral iron therapy as IFA tablets and 1500 IU of vitamin D3 as capsule for three months. The pa
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Individuals aged 60 years and above, a permanent resident of the area, are expected to stay in the area for another six months, gives consent to participate in the study, screened to have mild to moderate anemia and absence of vitamin D deficiency will be eligible for the study.
Exclusion criteria
Exclusion criteria: Individuals with no anemia (Male: Hemoglobin >13gm/dl and Female: Hemoglobin >12gm/dl), with severe anemia (Hemoglobin <8gm/dl), known history of gastrointestinal & metabolic disorders, known history of chronic renal failure, received blood donations in last 6 months and regularly consuming nutritional supplements (Iron, folic acid, Vitamin B12, Vitamin D and other multivitamins and minerals) will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hemoglobin level in both the groupsTimepoint: From base line to 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in CRP level in both the groupsTimepoint: From base line to 12 weeks;Change in hepcidin level in both the groupsTimepoint: From base line to 12 weeks;Change in Para Thyroid Hormone level in both the groups.Timepoint: From base line to 12 weeks;Change in serum ferritin level in both the groupsTimepoint: From base line to 12 weeks;Change in vitamin D level in both the groupsTimepoint: From base line to 12 weeks | — |
Countries
India
Contacts
Public ContactFarhad Ahamed
AIIMS Kalyani
Outcome results
None listed